|
1
|
Markiewicz K, Zeman K, Kozar A and
Gołebiowska-Wawrzyniak M: Evaluation of selected cytokines in
children and adolescents with osteosarcoma at diagnosis-preliminary
report. Med Wieku Rozwoj. 15:25–31. 2011.In Polish. PubMed/NCBI
|
|
2
|
Daw NC, Neel MD, Rao BN, Billups CA, Wu J,
Jenkins JJ, Quintana J, Luchtman-Jones L, Villarroel M and Santana
VM: Frontline treatment of localized osteosarcoma without
methotrexate: results of the St. Jude Children's Research Hospital
OS99 trial. Cancer. 117:2770–2778. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeRegis CJ, Moore AS, Rand WM and Berg J:
Cisplatin and doxorubicin toxicosis in dogs with osteosarcoma. J
Vet Intern Med. 17:668–673. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moore-Maxwell CA, Datto MB and Hulette CM:
Chemotherapy-induced toxic leukoencephalopathy causes a wide range
of symptoms: a series of four autopsies. Mod Pathol. 17:241–247.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoneyama K, Konishi H, Yahata T, Fujita K,
Aoki Y, Doi D, Matsushima T, Kodama S, Honma S, Kato H, Nakayama H,
et al: A Phase II study of paclitaxel and carboplatin with a
biweekly schedule in patients with epithelial ovarian cancer:
Gynecologic cancer network trial. J Nippon Med Sch. 81:28–34. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Von Hoff DD, Goldstein D and Renschler MF:
Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer. N
Engl J Med. 370:479–480. 2014.PubMed/NCBI
|
|
7
|
Dank M, Budi L, Piko B, Mangel L, Erfan J,
Cseh J, Ruzsa A and Landherr L: First-line bevacizumab-paclitaxel
in 220 patients with metastatic breast cancer: Results from the
AVAREG study. Anticancer Res. 34:1275–1280. 2014.PubMed/NCBI
|
|
8
|
Orvedahl A, Sumpter R Jr, Xiao G, Ng A,
Zou Z, Tang Y, Narimatsu M, Gilpin C, Sun Q, Roth M, Forst CV, et
al: Image-based genome-wide siRNA screen identifies selective
autophagy factors. Nature. 480:113–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maycotte P, Aryal S, Cummings CT, Thorburn
J, Morgan MJ and Thorburn A: Chloroquine sensitizes breast cancer
cells to chemotherapy independent of autophagy. Autophagy.
8:200–212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakamura O, Hitora T, Akisue T, Kawamoto
T, Yamagami Y and Yamamoto T: Inhibition of induced autophagy
increases apoptosis of Nara-H cells. Int J Oncol. 39:1545–1452.
2011.PubMed/NCBI
|
|
11
|
Mani J, Vallo S, Rakel S, Antonietti P,
Gessler F, Blaheta R, Bartsch G, Michaelis M, Cinatl J, Haferkamp A
and Kögel D: Chemoresistance is associated with increased
cytoprotective autophagy and diminished apoptosis in bladder cancer
cells treated with BH3 mimetic (−)-Gossypol (AT-101). BMC Cancer.
15:2242015. View Article : Google Scholar
|
|
12
|
Monti E and Gariboldi MB: HIF-1 as a
target for cancer chemotherapy, chemosensitization and
chemoprevention. Curr Mol Pharmacol. 4:62–77. 2011. View Article : Google Scholar
|
|
13
|
Generali D, Buffa FM, Berruti A, Brizzi
MP, Campo L, Bonardi S, Bersiga A, Allevi G, Milani M, Aguggini S,
Papotti M, et al: Phosphorylated ERalpha, HIF-1alpha and MAPK
signaling as predictors of primary endocrine treatment response and
resistance in patients with breast cancer. J Clin Oncol.
27:227–234. 2009. View Article : Google Scholar
|
|
14
|
Zhao Y, Chen G, Zhang W, Xu N, Zhu JY, Jia
J, Sun ZJ, Wang YN and Zhao YF: Autophagy regulates hypoxia-induced
osteoclastogenesis through the HIF-1α/BNIP3 signaling pathway. Cell
Physiol. 227:639–648. 2012. View Article : Google Scholar
|
|
15
|
Zhang H, Bosch-Marce M, Shimoda LA, Tan
YS, Baek JH, Wesley JB, Gonzalez FJ and Semenza GL: Mitochondrial
autophagy is an HIF-1-dependent adaptive metabolic response to
hypoxia. Biol Chem. 283:10892–10903. 2008. View Article : Google Scholar
|
|
16
|
Wessel D and Flügge UI: A method for the
quantitative recovery of protein in dilute solution in the presence
of detergents and lipids. Anal Biochem. 138:141–143. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Adesida AB, Grady LM, Khan WS,
Millward-Sadler SJ, Salter DM and Hardingham TE: Human meniscus
cells express hypoxia inducible factor-1α and increased SOX9 in
response to low oxygen tension in cell aggregate culture. Arthritis
Res Ther. 9:R692007. View
Article : Google Scholar
|
|
18
|
Zeng Y, Yang X, Wang J, Fan J, Kong Q and
Yu X: Aristolochic acid I induced autophagy extenuates cell
apoptosis via ERK 1/2 pathway in renal tubular epithelial cells.
PLoS One. 7:e303122012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amarnath S, Flomerfelt FA, Costanzo CM,
Foley JE, Mariotti J, Konecki DM, Gangopadhyay A, Eckhaus M, Wong
S, Levine BL, June CH and Fowler DH: Rapamycin generates
anti-apoptotic human Th1/Tc1 cells via autophagy for induction of
xenogeneic GVHD. Autophagy. 6:523–541. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ
and Xu YH: Anti-tumor effect of betapaxilitaxel in glioblastoma
cells depends on p38 MAPK activation. Cancer Lett. 264:127–134.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang G, Li X, Huang F, Zhao J, Ding H,
Cunningham C, Coad JE, Flynn DC, Reed E and Li QQ: Antitumor effect
of betapaxilitaxel in non-small-cell lung cancer cells is mediated
via induction of cell cycle arrest and apoptotic cell death. Cell
Mol Life Sci. 62:881–893. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo B, Yang M, Liang D, Yang L, Cao J and
Zhang L: Cell apoptosis induced by zinc deficiency in osteoblastic
MC3T3-E1 cells via a mitochondrial-mediated pathway. Mol Cell
Biochem. 361:209–216. 2012. View Article : Google Scholar
|
|
23
|
Rasul A, Yu B, Yang LF, Ali M, Khan M, Ma
T and Yang H: Induction of mitochondria-mediated apoptosis in human
gastric adenocarcinoma SGC-7901 cells by kuraridin and
Nor-kurarinone isolated from Sophora flavescens. Asian Pac J Cancer
Prev. 12:2499–2504. 2011.
|
|
24
|
Granell S and Baldini G: Inclusion bodies
and autophagosomes: are ER-derived protective organelles different
than classical autophagosomes? Autophagy. 4:375–377. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Deretic V, Delgado M, Vergne I, Master S,
De Haro S, Ponpuak M and Singh S: Autophagy in immunity against
mycobacterium tuberculosis: a model system to dissect immunological
roles of autophagy. Curr Top Microbiol Immunol. 335:169–188.
2009.PubMed/NCBI
|
|
26
|
Hofius D, Munch D, Bressendorff S, Mundy J
and Petersen M: Role of autophagy in disease resistance and
hypersensitive response-associated cell death. Cell Death Differ.
18:1257–1262. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang T, Li Y, Park KA, Byun HS, Won M,
Jeon J, Lee Y, Seok JH, Choi SW, Lee SH, Man Kim J, et al:
Cucurbitacin induces autophagy through mitochondrial ROS production
which counteracts to limit caspase-dependent apoptosis. Autophagy.
8:559–576. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ait-Mohamed O, Battisti V, Joliot V,
Fritsch L, Pontis J, Medjkane S, Redeuilh C, Lamouri A, Fahy C,
Rholam M, Atmani D and Ait-Si-Ali S: Acetonic extract of Buxus
sempervirens induces cell cycle arrest, apoptosis and autophagy in
breast cancer cells. PLoS One. 6:e245372011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu HH, Kao SY, Liu TY, Liu ST, Huang WP,
Chang KW and Lin SC: Areca nut extract induced oxidative stress and
upregulated hypoxia inducing factor leading to autophagy in oral
cancer cells. Autophagy. 6:725–737. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bellot G, Garcia-Medina R, Gounon P,
Chiche J, Roux D, Pouysségur J and Mazure NM: Hypoxia-induced
autophagy is mediated through hypoxia-inducible factor induction of
BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol.
29:2570–2581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu
Y, Xie M, Yin X, Livesey KM, Loze MT, Tang D and Cao L:
DAMP-mediated autophagy contributes to drug resistance. Autophagy.
7:112–124. 2011. View Article : Google Scholar :
|
|
32
|
Carew JS, Nawrocki ST, Kahue CN, Zhang H,
Yang C, Chung L, Houghton JA, Huang P, Giles FJ and Cleveland JL:
Targeting autophagy augments the anticancer activity of the histone
deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug
resistance. Blood. 110:313–322. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Doublier S, Belisario DC, Polimeni M,
Annaratone L, Riganti C, Allia E, Ghigo D, Bosia A and Sapino A:
HIF-1 activation induces doxorubicin resistance in MCF7 3-D
spheroids via P-glycoprotein expression: a potential model of the
chemo-resistance of invasive micropapillary carcinoma of the
breast. BMC Cancer. 12:42012. View Article : Google Scholar : PubMed/NCBI
|
